According to a new study, Parkinson’s patients, who struggle against tics, spasm, tremors that usually occur when main medications is diminished, may be helped by a new drug.
Istradfeylline helps nerve and brain signals bypass and the spoiled dopamine system that be the cause of Parkinson.
In a trial 395 people with Parkinson who used levodopa (a well-known Parkinson’s drug) were found with 24% higher “off” than those who were using Istradfeylline. The “off” has been defined as a time when physical symptoms begins to appear after wearing off the drug levodopa.Similarly, in a group studied who took a placebo showed 10 % drop in “Off” time.
